Results from Ongoing Phase ½ Trial of SL-401 in Patients with Relapsed/Refractory CMML. EHA 2018.

Results from Ongoing Phase 1/2 Trial of SL-401 in Patients with Relapsed/Refractory CMML. EHA 2018.

Poster